In particular, established markers for breast cancer, including Ki-67, p53, Her-2neu and ER expression are very effective for identifying aggressive, invasive cancers, and for determining the most effect treatment strategy in these cases, but are less informative about the likelihood that a well-contained DCIS will progress to invasive cancer. The gene discussed is MKI67; the disease is ductal breast carcinoma in situ.